Raymond James analyst James Rollyson lowered the firm’s price target on NOV Inc. (NOV) to $16 from $19 and keeps an Outperform rating on the shares. NOV’s Q1 was largely as expected or slightly better, and longer-cycle activity generally seems to be proceeding according to plan, while the major incremental negative for NOV’s outlook is an assumed slowing of short-cycle activity, leading to softer orders, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NOV:
